PBYI

PBYI Operating Cash Flow (Statement)

$41.15MTTM · USD

Period ending:

PBYI TTM Cash from OperationsUSD
PBYI TTM Cash from Operations2008-09-30: -$21.29M2008-12-31: -$11.83M2009-03-31: -$15.10M2009-06-30: -$14.65M2009-09-30: -$18.02M2009-12-31: -$16.82M2010-03-31: -$16.03M2010-06-30: -$16.03M2010-09-30: -$13.65M2010-12-31: -$18.25M2011-03-31: -$15.75M2011-06-30: -$15.76M2011-09-30: -$20.80M2011-12-31: -$16.97M2012-03-31: -$15.28M2012-06-30: -$21.61M2012-09-30: -$21.01M2012-12-31: -$44.01M2013-03-31: -$59.73M2013-06-30: -$61.93M2013-09-30: -$66.30M2013-12-31: -$55.07M2014-03-31: -$53.61M2014-06-30: -$60.01M2014-09-30: -$72.32M2014-12-31: -$77.20M2015-03-31: -$110.18M2015-06-30: -$127.35M2015-09-30: -$139.90M2015-12-31: -$154.47M2016-03-31: -$139.47M2016-06-30: -$135.74M2016-09-30: -$133.76M2016-12-31: -$141.69M2017-03-31: -$142.70M2017-06-30: -$157.81M2017-09-30: -$177.82M2017-12-31: -$172.47M2018-03-31: -$142.68M2018-06-30: -$114.41M2018-09-30: -$66.76M2018-12-31: -$24.05M2019-03-31: -$33.90M2019-06-30: $27.99M2019-09-30: $27.94M2019-12-31: $22.41M2020-03-31: $26.97M2020-06-30: -$1.05M2020-09-30: $7.97M2020-12-31: $773.00K2021-03-31: $27.97M2021-06-30: $11.67M2021-09-30: $20.45M2021-12-31: $20.65M2022-03-31: -$21.91M2022-06-30: -$35.71M2022-09-30: -$28.95M2022-12-31: -$15.83M2023-03-31: $13.71M2023-06-30: $30.88M2023-09-30: $24.24M2023-12-31: $27.01M2024-03-31: $35.61M2024-06-30: $33.34M2024-09-30: $33.77M2024-12-31: $38.92M2025-03-31: $31.28M2025-06-30: $44.34M2025-09-30: $42.99M2025-12-31: $41.80M2026-03-31: $53.61M2026-06-30: $41.15M$53.61M-$177.82M
2008-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM); reported in USD. TTM flows use four complete reported quarters.

PBYI operating cash flow (statement) history

Net cash provided by operating activities. The available trailing twelve months (ttm) series contains 72 observations from Sep 30, 2008 to Jun 30, 2026.

Puma Biotechnology Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
41,148,000
53,606,000
41,802,000
42,990,000
44,339,000
31,284,000
38,918,000
33,766,000
33,343,000
35,612,000
27,009,000
24,237,000
30,881,000
13,711,000
-15,827,000
-28,945,000
-35,706,000
-21,906,000
20,650,000
20,450,000
11,672,000
27,974,000
773,000
7,974,000
-1,053,000
26,966,000
22,406,000
27,940,000
27,985,000
-33,899,000
-24,052,000
-66,761,000
-114,406,000
-142,681,000
-172,470,000
-177,822,000
-157,806,000
-142,704,000
-141,690,000
-133,760,000
-135,736,000
-139,473,000
-154,468,000
-139,898,000
-127,353,000
-110,179,000
-77,203,000
-72,321,000
-60,013,000
-53,614,000
-55,067,000
-66,297,378
-61,927,378
-59,727,757
-44,011,999
-21,012,482
-21,610,482
-15,278,103
-16,966,861
-20,795,000
-15,756,000
-15,752,000
-18,246,000
-13,650,000
-16,034,000
-16,026,000
-16,815,000
-18,022,000
-14,654,000
-15,099,000
-11,834,000
-21,293,000

Compare operating cash flow (statement)

All PBYI financial metrics · PBYI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.